CAS 122211-62-5

Berkeleylactone E

CAS : 122211-62-5

Berkeleylactone E is a potent anticancer agent that works by inhibiting kinase activity and inducing apoptosis in cancer cells. This natural compound selectively targets cancer cells, leaving healthy cells unharmed. Berkeleylactone E has been shown to inhibit the activity of cyclin-dependent kinases, which are essential for cell cycle progression and tumor growth. By blocking these kinases, Berkeleylactone E halts the cell cycle and triggers apoptosis in cancer cells. This medicinal compound also inhibits the production of proteins that promote cancer cell survival, making it a promising candidate for cancer treatment. With its unique properties as an inhibitor of kinase activity and inducer of apoptosis, Berkeleylactone E represents a promising avenue for developing new cancer therapies.

Formule : C₂₀H₃₂O₇

Degré de pureté : Min. 95%

Masse moléculaire : 384.5 g/mol

Ref: 3D-XEA21162

Berkeleylactone E

CAS : 122211-62-5

Berkeleylactone E, a macrolide antibiotic [1], exhibits antimicrobial properties.

Formule : C₂₀H₃₂O₇

Couleur et forme : Solid

Masse moléculaire : 384.469

Ref: TM-T85067